Catalent, Inc. to Present at Two Investor Conferences in May

Bank of America Merrill Lynch Health Care Conference 2015

SOMERSET, N.J.--()--Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Matthew Walsh, Executive Vice President & Chief Financial Officer, will present at the following two investor conferences in May.

  • The Deutsche Bank 40th Annual Health Care Conference in Boston, MA, on Thursday, May 7, 2015 at 12:50 p.m. ET.
  • The Bank of America Merrill Lynch 2015 Health Care Conference in Las Vegas, NV, on Tuesday, May 12, 2015 at 11:20 a.m. PT.

A live webcast of Catalent’s presentation will be accessible through the Company’s website at http://investor.catalent.com and will be available for replay for 90 days following each event.

About Catalent, Inc.

Catalent, Inc. (NYSE:CTLT) is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,000 people, including over 1,000 scientists, at 30 facilities across 5 continents and in fiscal 2014 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, please visit www.catalent.com.

More products. Better treatments. Reliably supplied.™

Contacts

Investor Contact:
Thomas Castellano, Catalent, Inc.
Jeremy Feffer, Bertner Advisors, LLC
732-537-6325
investors@catalent.com

Catalent, Inc.